Huaguan Biotechnology
Beijing · Founded 2018
About Huaguan Biotechnology
Huaguan Biotechnology provides high-quality integrated drug research and development services for customers. This includes Sihuan Pharmaceutical, Sichuan Kelun, Tianjin Tasly, Beijing Yabao, Huasu Pharmaceutical, and other well-known domestic pharmaceutical companies, as well as Suzhou Amate, Shanghai Fuqi, Jiangsu Ya Sheng, and other scientific and technological innovation enterprises, the team development ability has been recognized by the industry and has attracted a number of listed companies such as Sihuan Pharmaceutical to inject capital.
Company Facts
- Founded: 2018
- Operating status: Active
- Company type: For Profit
- IPO status: Private
- Employees: 101 – 250
- Total funding: $14.4M
- Funding stage: Late Stage Venture
- Last round: Series C (Feb 2026)
- Website: chempion.com.cn
- Phone: 010-80781866/186 0133 1139
Industries & Categories
Biopharma, Biotechnology, Medical, Pharmaceutical
Canonical: https://fsome.com/organization/huaguan-biotechnology-3302913 · For the full interactive profile (charts, investors, team, acquisitions, press), please enable JavaScript.